Focus on the Host

A patient response-based gene expression signature can distinguish respiratory infections caused by viruses from those of bacterial or fungal origin.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Colorized transmission electron micrograph depicting the influenza A/CA/4/09 virusCDCA blood-based gene expression signature of patient response to pathogens can be used to detect respiratory viral infections and sufficiently distinguish them from their non-viral counterparts in an emergency department setting, researchers have shown in a proof-of-concept study published today (September 18) in Science Translational Medicine. The researchers suggested that their host response-based approach could help clinicians better identify viral infections, and therefore curb the unnecessary prescription of antibiotics.

Most infectious disease diagnostics work to identify traces of the pathogen, and therefore require some preexisting knowledge of the agent. The new test, from Duke University Medical Center’s Aimee Zaas and her colleagues, instead evaluates how strongly certain host genes are turned on or expressed in the presence of a pathogen.

“It’s an interesting paper. It takes a different approach from what we traditionally do in a microbiology lab, which is look for pathogens,” said James Mahony from McMaster University in Canada, who was not involved in the study. “Looking for host transcriptional patterns indicative of a viral infection versus a non-viral infection . . . is an interesting approach, and totally different from what I do as a clinical virologist.”

“Viruses do not have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo